Amblyopia, sometimes called ‘lazy eye’, is a prevalent but continuously ignored imaginative and prescient dysfunction that impacts 1-5% of the worldwide inhabitants. Its prevalence has reached as much as 5% in India. Whereas standard therapies exist and have confirmed efficient, they arrive with quite a few challenges and are sometimes met with resistance, particularly from younger kids. A Bengaluru-based health-tech startup is utilizing immersive digital actuality to deal with this situation.
Based in 2023, NeuraSim makes use of superior VR-based simulations to rewire the mind’s visible processing. It provides a breakthrough different to conventional remedies for amblyopia, equivalent to patching remedy.
“The standard remedy known as patching, the place we put a patch over the nice eye and let the mind be compelled to make use of the weaker eye. This takes 9 months, and youngsters usually drop out inside two to 3 months. In distinction, our immersive remedy improves imaginative and prescient ranging from 20 days of remedy, with leads to 45 days,” stated Ramesh S Ve, founder and CEO of NeuraSim, in an unique interplay with AIM.
VR-Primarily based Imaginative and prescient Remedy
Amblyopia normally happens in childhood when one eye is considerably weaker than the opposite. This leads the mind to suppress enter from the weaker eye. If left untreated, it can lead to everlasting imaginative and prescient impairment.
NeuraSim’s VR remedy provides a non-invasive, partaking, and scientifically validated strategy. By immersing sufferers in managed VR environments, the therapy stimulates the weaker eye whereas concurrently making certain the mind integrates inputs from each eyes.
“We have to dissociate one eye as being weak and the opposite as being robust. The mind is conditioned to solely use one eye, and we’ve got to recondition it and rewire it. Digital actuality, by design, brings in that facility,” Ramesh stated.
NeuraSim VR headset
The remedy consists of immersive VR simulations customised for every affected person’s wants. The know-how has been validated by medical testing, and the outcomes are promising.
“To our shock, inside 45 periods, from close to blindness within the weak eye, a seven-year-old baby gained virtually 600% enchancment. In the present day, that baby has steady imaginative and prescient which she wouldn’t in any other case have had,” Ramesh shared.
This type of therapy additionally addresses the scarcity of ophthalmologists and optometrists within the nation. “For India’s 1.4 billion inhabitants, we simply have round 30,000 ophthalmologists and 25,000-30,000 optometrists. Even when we embody opticians and different assist workers, the whole workforce is nearly one lakh. That is nowhere close to sufficient to offer sufficient eye take care of the rising inhabitants,” Ramesh emphasised.
Software program and {Hardware} Combo
NeuraSim, based in 2023 and headquartered in Bengaluru, has its analysis and growth incubated on the Manipal Bioincubator. The corporate initially acquired funding from a Biotechnology Trade Analysis Help Council (BIRAC) grant and later secured a €1 million Indo-European analysis grant to develop its VR know-how.
NeuraSim’s VR answer is constructed on years of analysis and medical trials. Ramesh, who has a background in public well being and imaginative and prescient science, labored with main establishments like Johns Hopkins College and Manipal Academy of Increased Training earlier than founding NeuraSim with Girish Somvanshi. His in depth expertise in epidemiological research and telehealth impressed the creation of the startup.
Regardless of being a comparatively younger startup and even just lately getting featured in Shark Tank India, the place they didn’t obtain funding, NeuraSim has already gained traction amongst India’s prime eye care establishments and acquired a lot of inquiries following the airing of that episode.
Aravind Eye Care, an ophthalmology establishment identified worldwide, was amongst its first paying clients. “We wished to validate if there was an actual enterprise case. In the present day, we’ve got over 20 clients, together with repeat purchasers from the Aravind chain,” Ramesh stated.
NeuraSim provides two pricing fashions for its VR-based amblyopia remedy. One of many fashions features a monitor, mini-computer, and VR gadget and is priced at ₹4.5 lakh. For this variant, remedy is run by a clinician. In the meantime, the second mannequin is accessible for lease at ₹12,000 monthly. “That involves round ₹200 per session, making it extra accessible for fogeys who would in any other case spend ₹400 on journey for clinic visits,” he additional stated.
Whereas VR-based imaginative and prescient remedy exhibits nice promise, the street to adoption doesn’t come with out its challenges. One of many major hurdles was the supply of appropriate VR {hardware}.
Initially, NeuraSim relied on imported units like Pico, which later turned troublesome to obtain because of geopolitical points. This pushed the corporate to companion with Pune-based startup Query What’s Actual (QWR) to fabricate VR headsets domestically.
Hurdles Stay
“We’re very proud to say that we are actually {hardware} agnostic. Our software program can work on QWR units, Oculus Quest, and different VR platforms. However as a medical gadget firm, we’d like a {hardware} companion who can assist regulatory compliance and long-term servicing,” Ramesh famous.
By transitioning to home {hardware} companions, the corporate has managed to chop prices by almost a 3rd, making the answer extra inexpensive.
Furthermore, parental scepticism about VR-based remedy posed an preliminary barrier. Many dad and mom questioned whether or not prolonged VR publicity was protected for kids.
“We clarify that this can be a momentary, structured therapy, not long-term VR publicity. It’s like a prescription, a managed use of VR to enhance imaginative and prescient operate,” he clarified.
Wanting forward, NeuraSim goals to broaden its VR remedy providing past amblyopia. The startup is growing AI-based retinal imaging instruments and neurorehabilitation packages for circumstances equivalent to glaucoma and Parkinson’s illness. The corporate’s roadmap additionally consists of increasing its medical partnerships, rising accessibility by home-based remedy options, and coming into worldwide markets.
“Our goal is to be in 150-200 clinics by December 2025. Every clinic treating at the least 5 sufferers monthly for dwelling remedy will permit us to achieve a scale the place imaginative and prescient remedy turns into extra accessible,” Ramesh outlined.
With the rising variety of sufferers, AI, telehealth, and VR-based remedy may help bridge the hole in healthcare entry, making certain extra folks obtain well timed therapy regardless of the scarcity of specialists – a imaginative and prescient NeuraSim is actively working in direction of.
The submit This Shark Tank-Featured Bengaluru Startup is Tackling ‘Lazy Eye’ with VR Remedy appeared first on Analytics India Journal.
